山慈菇在中晚期肺癌的药理作用及作用机制研究进展
Research Progress on the Pharmacological Effects and Mechanisms of Tricholoma lobayense in Mid-to-Late Stage Lung Cancer
DOI: 10.12677/acm.2025.1561751, PDF,   
作者: 程 帅:黑龙江中医药大学研究生院,黑龙江 哈尔滨;刘松江*:黑龙江中医药大学附属第一医院肿瘤科,黑龙江 哈尔滨
关键词: 山慈菇中晚期肺癌药理作用Tricholoma lobayense Mid-to-Late Stage Lung Cancer Pharmacological Effects
摘要: 山慈菇(Tricholoma lobayense)作为一种传统中药材,近年来在肺癌(lung cancer)治疗中的药理作用备受关注。研究表明,山慈菇中富含多种生物活性成分,如三萜类、酚酸类及多糖等,其对肿瘤细胞的抑制效应与其化学成分的复杂相互作用密切相关。山慈菇通过多种机制发挥抗肿瘤活性,主要包括抑制肺癌细胞的增殖、诱导凋亡、抑制肿瘤细胞的转移与侵袭能力。山慈菇还可以通过调节肿瘤微环境和增强宿主免疫反应,促进局部免疫细胞的活化,从而达到增强抗肿瘤免疫作用的效果。这一系列作用可能通过约束血管生成、调节细胞代谢及改善肿瘤微环境的功能实现。尽管山慈菇的潜在不良反应尚需进一步研究与确证,但其在中晚期肺癌治疗中展现出的多重药理效应为今后药物开发和临床应用提供了新的方向。本综述对山慈菇的药理作用及其在抗肺癌方面的作用机制进行了系统归纳,以期为后续研究提供理论基础与实践指导。
Abstract: Tricholoma lobayense, a traditional Chinese medicinal herb, has garnered significant attention in recent years for its pharmacological effects in the treatment of lung cancer. Studies indicate that Tricholoma lobayense is rich in bioactive compounds, including triterpenoids, phenolic acids, and polysaccharides, and its antitumor effects are closely linked to the complex interactions among these chemical components. Tricholoma lobayense exerts its anticancer activity through multiple mechanisms, primarily involving the inhibition of lung cancer cell proliferation, induction of apoptosis, and suppression of tumor metastasis and invasiveness. Additionally, Tricholoma lobayense enhances antitumor immunity by modulating the tumor microenvironment and boosting host immune responses, thereby promoting the activation of local immune cells. These effects may be achieved through mechanisms such as inhibiting angiogenesis, regulating cellular metabolism, and improving tumor microenvironment functionality. Although further research is required to validate its potential adverse effects, the multifaceted pharmacological properties of Tricholoma lobayense in treating mid-to-late stage lung cancer offer promising directions for future drug development and clinical applications. This review systematically summarizes the pharmacological roles and mechanisms of Tricholoma lobayense in combating lung cancer, aiming to provide theoretical foundations and practical guidance for subsequent research.
文章引用:程帅, 刘松江. 山慈菇在中晚期肺癌的药理作用及作用机制研究进展[J]. 临床医学进展, 2025, 15(6): 491-497. https://doi.org/10.12677/acm.2025.1561751

参考文献

[1] 樊代明, 陆舜, 王俊, 等. 中国肿瘤整合诊治指南肺癌2022 [M]. 天津: 天津出版传媒集团, 天津科学技术出版社, 2022.
[2] 国家药典委员会. 中华人民共和国药典: 一部[S]. 北京: 中国医药科技出版社, 2020.
[3] Wu, X., Li, W., Chen, J., Zhai, J., Xu, H., Ni, L., et al. (2019) Chemical Constituents and Biological Activity Profiles on Pleione (Orchidaceae). Molecules, 24, Article 3195. [Google Scholar] [CrossRef] [PubMed]
[4] Zhang, L., Yang, K., Wang, M., Zeng, L., Sun, E., Zhang, F., et al. (2021) Exploring the Mechanism of Cremastra appendiculata (SUANPANQI) against Breast Cancer by Network Pharmacology and Molecular Docking. Computational Biology and Chemistry, 94, Article ID: 107396. [Google Scholar] [CrossRef] [PubMed]
[5] 芦艺凡, 王宇, 姜婷月, 等. 山慈菇水提物抗肝癌有效部位筛选及其对肝癌小鼠肿瘤血管生成的影响[J]. 中草药, 2025, 56(5): 1607-1616.
[6] 肖培根. 新编中药志[M]. 北京: 化学工业出版社, 2000: 100-104.
[7] 张超, 高一军, 孙启慧, 等. 山慈菇化学成分信息库的构建[J]. 中药材, 2024, 47(12): 3165-3176.
[8] Kovács, A., Vasas, A. and Hohmann, J. (2008) Natural Phenanthrenes and Their Biological Activity. Phytochemistry, 69, 1084-1110. [Google Scholar] [CrossRef] [PubMed]
[9] 汤喜兰, 刘建勋, 李磊. 中药有机酸类成分的药理作用及在心血管疾病的应用[J]. 中国实验方剂学杂志, 2012, 18(5): 243-246.
[10] 徐小娟, 蔡懿鑫, 毛宇, 等. 山慈菇多糖对荷H22肝癌小鼠的抗肿瘤机制研究[J]. 食品研究与开发, 2015, 36(7): 23-25.
[11] Chang, J., Lai, S., Chen, W., Hung, W., Chow, J., Hsiao, M., et al. (2017) Quercetin Suppresses the Metastatic Ability of Lung Cancer through Inhibiting Snail-Dependent Akt Activation and Snail-Independent ADAM9 Expression Pathways. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1864, 1746-1758. [Google Scholar] [CrossRef] [PubMed]
[12] 方健, 王辰男, 孟庆刚. 山慈菇提取物对肝癌细胞Huh7增殖、凋亡的影响及其机制[J]. 山东医药, 2020, 60(11): 11-15.
[13] Green, D.R., Galluzzi, L. and Kroemer, G. (2014) Metabolic Control of Cell Death. Science, 345, Article ID: 1250256. [Google Scholar] [CrossRef] [PubMed]
[14] 于林楠, 翟宏颖. 山慈菇提取物对结肠癌HT29细胞凋亡的影响[J]. 中国民族民间医药, 2016, 25(16): 17-19.
[15] Mierke, C.T. (2019) The Matrix Environmental and Cell Mechanical Properties Regulate Cell Migration and Contribute to the Invasive Phenotype of Cancer Cells. Reports on Progress in Physics, 82, Article ID: 064602. [Google Scholar] [CrossRef] [PubMed]
[16] 肖开. 中药山慈菇辅助治疗晚期非小细胞肺癌的临床效果[J]. 慢性病学杂志, 2021, 22(1): 142-143, 146.
[17] 赵凌云. 血清MMP-9和LCN-2水平在乳腺癌患者中表达意义及相关性分析[J]. 分子诊断与治疗杂志, 2020, 12(6): 756-759.
[18] 程清波, 杨艳萍, 王滢, 等. 山慈菇对肝癌细胞凋亡和上皮间质转化的影响[J]. 中医学报, 2021, 36(10): 2202-2207.
[19] 唐纯明, 何自力, 李军. 山慈菇提取物对肝癌细胞增殖及TNF-α、IL-1β、IL-6表达的影响[J]. 山东医药, 2020, 60(8): 11-14.
[20] 汪利凤, 周利鹏, 肖萍, 等. 超声引导下胸部神经阻滞对乳腺癌根治术患者应激反应及炎症细胞因子的影响[J]. 中国妇幼保健, 2021, 36(3): 678-683.
[21] 刘颖, 马丽杰, 董欣敏, 等. 山慈菇正丁醇提取物对NR8383细胞分泌的IL-1β和TNF-α水平的影响[J]. 科学技术与工程, 2019, 19(24): 93-97.
[22] 张子英. PD-L1调节蒙、中、藏常用抗癌药山慈菇酯提物抗4T1乳腺癌的分子免疫药理学机制[Z]. 呼和浩特: 内蒙古医科大学, 2023-07-18.
[23] 剧雪华. IL-1β和IL-6在结直肠癌患者中的表达及意义[J]. 河北医药, 2015, 37(18): 2807-2810.
[24] Su, B., Luo, T., Zhu, J., Fu, J., Zhao, X., Chen, L., et al. (2015) Interleukin‐1β/Iinterleukin‐1 Receptor‐Associated Kinase 1 Inflammatory Signaling Contributes to Persistent Gankyrin Activation during Hepatocarcinogenesis. Hepatology, 61, 585-597. [Google Scholar] [CrossRef] [PubMed]
[25] 王宏伟, 田欣圆, 于蕾. 山慈菇的化学成分及其抗肿瘤作用机制研究进展[J]. 内蒙古医科大学学报, 2022, 44(3): 305-309.
[26] 王骁, 范焕芳, 李德辉, 等. 山慈菇抗肿瘤作用研究进展[J]. 江苏中医药, 2023, 55(2): 74-76.
[27] 陈俊良, 王风华. 2021版CSCO胃癌诊疗指南转移性胃癌更新解读[J]. 中国肿瘤临床, 2022, 49(7): 325-330.
[28] 李余先, 杜刚, 官丽丽, 等. 山慈菇提取物抑制血管形成的药效学研究[J]. 吉林农业, 2015(21): 76-77.
[29] Zhang, X., Bi, C., Shi, H. and Li, X. (2021) Structural Studies of a Mannoglucan from Cremastra appendiculata (Orchidaceae) by Chemical and Enzymatic Methods. Carbohydrate Polymers, 272, Article ID: 118524. [Google Scholar] [CrossRef] [PubMed]
[30] 林明珠, 赵岩, 蔡恩博, 等. β-谷甾醇对H22荷瘤小鼠体内抗肿瘤作用[J]. 中国公共卫生, 2017, 33(12): 1797-1800.
[31] Liu, L., Li, J., Zeng, K., Jiang, Y. and Tu, P. (2016) Five New Biphenanthrenes from Cremastra appendiculata. Molecules, 21, Article 1089. [Google Scholar] [CrossRef] [PubMed]
[32] 夏文斌, 薛震, 李帅, 等. 杜鹃兰化学成分及肿瘤细胞毒活性研究[J]. 中国中药杂志, 2005, 30(23): 1827-1830.